The Sarcoma Foundation of America is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and clinical research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. This RFP is in support of our overall mission to fund research and increase awareness and advocacy for sarcoma patients and their families. The goal of the SFA grant program is to encourage research that results in improved therapeutic options for sarcoma patients. The SFA encourages applications in all areas of sarcoma research, however the following areas of research are of particular interest: Immunotherapy; Omic characterization of sarcomas and definition of novel targets; Omic patterns of sensitivity and resistance to existing agents; Systemic therapy combinations; Gene Therapy

The total award amount is 51.508,25 € for one year. The grants are awarded on an annual cycle from June 1 to May 31.

For each awarded grant, funding of up to 51.508,25 € in total cost is available to cover equipment, supplies and other expenses in support of research within the period of performance

· Applicants must be an MD, DO, PhD, or international equivalent, inside or outside the U.S., with the skills, knowledge, and resources necessary to carry out the proposed sarcoma research;

· Each proposal must identify only one lead PI. The PI is responsible for the overall grant management, coordination and research oversight to include the deliverables;

· Applications from researchers outside of the U.S. must be able to provide a budget and accept funds in U.S. dollars;

In case of interest please click on "m'interessa"  and we will contact you.